FANJ
AMRI

Financial Architects (New Jersey)’s Albany Molecular Research Inc AMRI Stock Holding History

Financial Architects (New Jersey)’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10
Closed – – 1680
2017
Q2 		$0 Hold
10
– – ﹤0.01% 1716
2017
Q1 		$0 Hold
10
– – ﹤0.01% 1670
2016
Q4 		$0 Sell
10
-700
-99% -$11.9K ﹤0.01% 1561
2016
Q3 		$12K Hold
710
– – ﹤0.01% 969
2016
Q2 		$10K Buy
+710
New +$10.4K ﹤0.01% 994

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Financial Architects (New Jersey)'s AMRI Position: Q3 2017 in Review

Financial Architects (New Jersey) sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 10 shares.

Financial Architects (New Jersey) first reported a position in AMRI in Q2 2016 and held it in 5 quarters. The position peaked at $12K in Q3 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Financial Architects (New Jersey) reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 10 Albany Molecular Research Inc shares in Q3 2017.
  • Financial Architects (New Jersey) first reported a position in Albany Molecular Research Inc in Q2 2016 and held it in 5 quarters.
  • Financial Architects (New Jersey)'s Albany Molecular Research Inc position peaked at $12K in Q3 2016.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2017, filed 23 Oct 2017.